Lupin acquires exclusive rights to develop, manufacture TTP inhalation products
Pharma major Lupin Ltd on Thursday said its wholly-owned arm Lupin Inc has inked a pact with TTP Plc to acquire exclusive worldwide rights to develop, manufacture and commercialise inhalation products, using the latter's soft-mist inhalation technology platform.
Lupin acquires exclusive rights to develop, manufacture TTP inhalation products. Source: Reuters